Results 141 to 150 of about 48,639 (314)

Predicting early graft loss in pancreas transplantation using novel imaging techniques: are we there yet? [PDF]

Hepatobiliary Surg Nutr, 2023
Ray S, Reichman TW.
europepmc   +1 more source

Enhancing antitumor immunity through the combination of cholesterolized TLR7 agonist liposomes and radiotherapy: a role for IL‐1β and the inflammasome pathway

Cancer Communications, EarlyView.
Abstract Background Radiotherapy (RT) is a key treatment modality in cancer therapy, utilizing high‐energy radiation to directly kill tumor cells. Recent research has increasingly highlighted RT's potential to indirectly enhance antitumor immunity. However, this immune activation alone often fails to generate sustained systemic antitumor responses.
Xuejiao Han, Yuan Cheng, Dandan Wan, Aqu Alu, Ziqi Zhang, Zhenfei Bi, Manni Wang, Yan Tang, Weiqi Hong, Siyuan Chen, Li Chen, Yuquan Wei   +11 more
wiley   +1 more source

Pancreas transplantation

Nephrology Dialysis Transplantation, 2020
Andrew, Sutherland, Lorna, Marson
openaire   +2 more sources

Outcomes of pancreas transplantation in patients with underlying inflammatory bowel disease: a retrospective case series. [PDF]

Ann Med Surg (Lond), 2023
Ray S, Yousuf A, Dharia A, Ayoub G, Parmentier C, Norgate A, Schiff J, Shwaartz C, Selzner M, Reichman TW.   +9 more
europepmc   +1 more source

Normalization of insulin sensitivity and glucose homeostasis in type I diabetic pancreas transplant recipients: a 48-month cross-sectional study--a clinical research center study. [PDF]

, 1996
Daryl A. Cottrell
openalex   +1 more source

FLOT1 Is a Novel Serum Biomarker of Ovarian Cancer Targeted by N6‐methyladenosine Modification Inhibition

Cell Biology International, EarlyView.
ABSTRACT Ovarian cancer (OC) is a deadly disease and lacks a precise marker for diagnosis worldwide. Our previous work has shown the overexpression of flotillin‐1 (FLOT1) in OC tissue. To improve diagnostic sensitivity and accuracy, we evaluated the serum level of FLOT1 in OC patients and found that the serum concentration of FLOT1 as well as CA125 was
Bin Guan, Qi Lu, Junyu Chen, Jingyi Fang, Zhenyu Liu, Wei Li, Lingyun Zhang, Guoxiong Xu   +7 more
wiley   +1 more source

Beyond prediction: Off‐target uses of artificial intelligence‐based predictive analytics in a learning health system

Learning Health Systems, Volume 7, Issue 1, January 2023., 2023
Abstract Introduction Artificial‐intelligence (AI)‐based predictive analytics provide new opportunities to leverage rich sources of continuous data to improve patient care through early warning of the risk of clinical deterioration and improved situational awareness.Part of the success of predictive analytic implementation relies on integration of the ...
Jessica Keim‐Malpass, Liza P. Moorman, Oliver J. Monfredi, Matthew T. Clark, Jamieson M. Bourque   +4 more
wiley   +1 more source

Evaluating Global and Temporal Trends in Pancreas and Islet Cell Transplantation: Public Awareness and Engagement

Clinics and Practice
Background: Pancreas transplantation is a crucial surgical intervention for managing diabetes, but it faces challenges such as its invasive nature, stringent patient selection criteria, organ scarcity, and centralized expertise.
Oscar A. Garcia Valencia, Charat Thongprayoon, Caroline C. Jadlowiec, Shennen A. Mao, Napat Leeaphorn, Pooja Budhiraja, Nadeen Khoury, Pradeep Vaitla, Supawadee Suppadungsuk, Wisit Cheungpasitporn   +9 more
doaj   +1 more source

Revitalizing pancreas transplantation: creation of a hands-on training course for pancreas allograft procurement, backbench preparation, and transplantation. [PDF]

Global Surg Educ, 2023
Lutz AJ, Diwan TS, Hobeika MJ, Dunn T, Proffitt E, Reynolds T, Fridell JA.   +6 more
europepmc   +1 more source

β‐Glucuronidase‐Responsive Albumin‐Binding Prodrug of Colchicine‐Site Binders for Selective Cancer Therapy

ChemMedChem, EarlyView.
This study presents a β‐glucuronidase‐responsive albumin‐binding prodrug enabling the selective release within the tumor microenvironment of an Isocombretastatin A‐4 analog. In triple‐negative breast cancer (TNBC) mouse models, this prodrug demonstrated significant tumor growth inhibition, highlighting potential for enhanced therapeutic selectivity and
Alexandra Bordes, Isabelle Opalinski, Fabien Thoreau, Olivier Provot, Abdallah Hamze, Mouad Alami, Sébastien Papot   +6 more
wiley   +1 more source